Evidence map›Paper›PMID 39977316›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Structural requirements of KAI2 ligands for activation of signal transduction.

Rito Kushihara, Akihiko Nakamura, Katsuki Takegami, Yoshiya Seto, Yusuke Kato, Hideo Dohra, Toshiyuki Ohnishi, Yasushi Todoroki, Jun Takeuchi

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Negative feedback regulation of karrikin signaling inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Molecular insights into volatile organic compound sensing and signaling in plants.The Plant journal : for cell and molecular biology · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rito KushiharaDepartment of Agriculture, Graduate School of Science and Technology, Shizuoka University, Shizuoka 422-8529, Japan.
Akihiko NakamuraDepartment of Applied Life Sciences, Faculty of Agriculture, Shizuoka University, Shizuoka 422-8529, Japan.ORCID 0000-0003-0409-5759
Katsuki TakegamiDepartment of Agriculture, Graduate School of Science and Technology, Shizuoka University, Shizuoka 422-8529, Japan.
Yoshiya SetoLaboratory of Plant Chemical Regulation, Department of Agricultural Chemistry, School of Agriculture, Meiji University, Kanagawa 214-8571, Japan.ORCID 0000-0003-1593-5717
Yusuke KatoLaboratory of Plant Chemical Regulation, Department of Agricultural Chemistry, School of Agriculture, Meiji University, Kanagawa 214-8571, Japan.
Hideo DohraResearch Institute of Green Science and Technology, Shizuoka University, Shizuoka 422-8529, Japan.ORCID 0000-0002-3919-3538
Toshiyuki OhnishiDepartment of Applied Life Sciences, Faculty of Agriculture, Shizuoka University, Shizuoka 422-8529, Japan.
Yasushi TodorokiDepartment of Applied Life Sciences, Faculty of Agriculture, Shizuoka University, Shizuoka 422-8529, Japan.
Jun TakeuchiDepartment of Applied Life Sciences, Faculty of Agriculture, Shizuoka University, Shizuoka 422-8529, Japan.ORCID 0000-0003-3049-8965

Funding

JST ACT-X JPMJAX21BE
6 · The paper itself

Abstract

Karrikin Insensitive 2 (KAI2), identified as the receptor protein for karrikins (KARs), which are smoke-derived seed germination stimulants, belongs to the same α/β-hydrolase family as D14, the receptor for strigolactones (SLs). KAI2 is believed to recognize an endogenous butenolide (KAI2 ligand; KL), but the identity of this compound remains unknown. Recent studies have suggested that ligand hydrolysis by KAI2 is a prerequisite for receptor activation to induce interaction with the target proteins, similar to the situation with D14. However, direct experimental evidence has been lacking. Here, we designed KAI2 ligands (carba-dMGers) whose butenolide rings were modified so that they cannot be hydrolyzed or dissociated from the original ligand molecule by KAI2, by structurally modifying dMGer, a potent and selective KAI2 agonist. Using these dMGer analogs, we found that the strongly bioactive ligand, (+)-dMGer, was hydrolyzed by KAI2 at a lower enzymatic rate compared with the weakly bioactive ligand, (+)-1'-carba-dMGer, and the hydrolyzed butenolide ring of (+)-dMGer was transiently trapped in the catalytic pocket of KAI2. Additionally, structural analysis revealed that (+)-6'-carba-dMGer bound to the catalytic pocket of KAI2 in the unhydrolyzed state. However, this binding did not induce the interaction between KAI2 and SMAX1, indicating that ligand binding to the receptor alone was not sufficient for KAI2 signaling. This study showed experimental data from a ligand structure-activity study that ligand hydrolysis and subsequent covalent adduct formation with the catalytic triad plays a key role in KAI2 activation, providing insight into the chemical structure of the

Indexed as

4-ButyrolactoneArabidopsisArabidopsis ProteinsSignal TransductionHydrolasesHydrolysisLigands4-ButyrolactoneArabidopsis ProteinsbutenolideHydrolasesLigandsKAI2ligand hydrolysisreceptor

Identifiers

PMID39977316
PMCPMC11874195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.